Health Care·Health Care Equipment·$23.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.17 | N/A | +16.44% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.17 | N/A | +16.44% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on the company's ability to navigate challenges. They emphasized their commitment to innovation and customer satisfaction.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to enhance product offerings and customer engagement.
Dexcom's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.08%. The lack of revenue figures and guidance may have contributed to investor caution.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERIPRISE FINL INC
Apr 24, 2023